Co-authored in collaboration with Cannabiscientia SA, The Pharmaceutical Cannabis Report: 3rd Edition gives a clear and detailed account of all activity involving cannabis and cannabinoids in the landscape of pharmaceutical medicine, at a global level. The main topics covered include an analysis of the relevant landscape in clinical trials, patents and innovation. This free-to-watch webinar…

The recent HHS recommendation regarding cannabis rescheduling from a category 1 to a category 3 presents some interesting considerations for expert testimony and advocacy for clients within the industry. Grab your lunch and join NABCL and Sheilds for this special 2 hour lunch and learn featuring a unique approach to understanding the science behind cannabis’…